
Spero Biopharma Israeli Company
Spero Biopharma is the developer of Ladostigil, a drug designed to treat mild cognitive impairment before it progresses to Alzheimer's disease.
Health Tech & Life Sciences
Biopharma
Biotechnology
Health Care
Wellness
Alternatives
No alternatives listed yet.
Suggest an Alternative
Founders
Office Locations
Ramat Hasharon, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/spero-biopharma
[2]
crunchbase.com
- https://www.crunchbase.com/organization/spero-biopharma
External links are provided for reference and verification purposes.